Tech Company Financing Transactions
Lembas Funding Round
Lembas, based in Tel Aviv, raised $3.6 million from Bluestein Ventures, Fresh.Fund and Longevity Venture Partners.
Transaction Overview
Company Name
Announced On
6/11/2025
Transaction Type
Venture Equity
Amount
$3,600,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to accelerate the commercialization of its GLP-1 Edge bioactive, expand its AI discovery platform, and deepen commercial agreements across the ingredients, food and supplements value chain.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Tel Aviv, Undisclosed
Israel
Tel Aviv, Undisclosed
Israel
Phone
Undisclosed
Website
Email Address
Overview
Lembas is pioneering a new category of science-backed supplements and functional ingredients for healthy and effective weight management. Lembas partners with supplement, food and beverage ingredient and brand companies looking to create the future of science-backed weight management products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shay Hilel
Browse more venture capital transactions:
Prev: 6/11/2025: Nexus IT venture capital transaction
Next: 6/11/2025: Glean Technologies venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs